204 related articles for article (PubMed ID: 23540505)
1. Advances in pathogenesis and treatment of pruritus.
Bolier R; Oude Elferink RP; Beuers U
Clin Liver Dis; 2013 May; 17(2):319-29. PubMed ID: 23540505
[TBL] [Abstract][Full Text] [Related]
2. Cholestatic Itch Management.
Mittal A
Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
[TBL] [Abstract][Full Text] [Related]
3. The challenge of cholestatic pruritus.
Bolier AR; Peri S; Oude Elferink RP; Beuers U
Acta Gastroenterol Belg; 2012 Dec; 75(4):399-404. PubMed ID: 23402082
[TBL] [Abstract][Full Text] [Related]
4. Understanding and Treating Pruritus in Primary Biliary Cholangitis.
Carrion AF; Rosen JD; Levy C
Clin Liver Dis; 2018 Aug; 22(3):517-532. PubMed ID: 30259850
[TBL] [Abstract][Full Text] [Related]
5. Pruritus in chronic cholestatic liver disease.
Bunchorntavakul C; Reddy KR
Clin Liver Dis; 2012 May; 16(2):331-46. PubMed ID: 22541702
[TBL] [Abstract][Full Text] [Related]
6. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
Kremer AE; Oude Elferink RP; Beuers U
Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
[TBL] [Abstract][Full Text] [Related]
7. [Physiopathology and management of cholestatic pruritus in children].
Thébaut A; Debray D; Gonzales E
Arch Pediatr; 2017 Jul; 24(7):682-688. PubMed ID: 28583778
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus.
Fuhrmann V; Drolz A; Trauner M
Liver Int; 2011 Sep; 31 Suppl 3():31-3. PubMed ID: 21824282
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
10. Management of Chronic Hepatic Itch.
Düll MM; Kremer AE
Dermatol Clin; 2018 Jul; 36(3):293-300. PubMed ID: 29929600
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
Beuers U; Wolters F; Oude Elferink RPJ
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
[TBL] [Abstract][Full Text] [Related]
12. Advances in pathogenesis and management of pruritus in cholestasis.
Kremer AE; Bolier R; van Dijk R; Oude Elferink RP; Beuers U
Dig Dis; 2014; 32(5):637-45. PubMed ID: 25034299
[TBL] [Abstract][Full Text] [Related]
13. Pruritus associated with cholestasis. A review of pathogenesis and management.
Khandelwal M; Malet PF
Dig Dis Sci; 1994 Jan; 39(1):1-8. PubMed ID: 8281842
[No Abstract] [Full Text] [Related]
14. Itch Management: Systemic Agents.
Pongcharoen P; Fleischer AB
Curr Probl Dermatol; 2016; 50():46-53. PubMed ID: 27578071
[TBL] [Abstract][Full Text] [Related]
15. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
Matsuzaki Y
J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
[No Abstract] [Full Text] [Related]
16. [Pruritus in liver disease. Pathogenesis and treatment].
Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and treatment of pruritus in cholestasis.
Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
[TBL] [Abstract][Full Text] [Related]
18. [Pruritus associated with cholestasis].
Terán A; Fábrega E; Pons-Romero F
Gastroenterol Hepatol; 2010 Apr; 33(4):313-22. PubMed ID: 19836105
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
Tandon P; Rowe BH; Vandermeer B; Bain VG
Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cholestatic pruritus in children.
Cies JJ; Giamalis JN
Am J Health Syst Pharm; 2007 Jun; 64(11):1157-62. PubMed ID: 17519457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
